Therefore, prostasin is a suppressor of the malignant phenotype in a wide range of cancers, explaining why reduced expression of prostasin in cancer cells correlated with less differentiated histology and poorer prognosis of the patients [40, 42–45]. Here, PRSS8 is linked to cancer.